[SYRS] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
07-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- 12.69%
YoY- -4.65%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 5,699 3,828 3,188 2,379 508 558 462 429.82%
PBT -30,130 -19,486 -17,196 -17,226 -19,729 -19,793 -19,455 33.68%
Tax 1,417 0 0 0 0 0 0 -
NP -30,130 -19,486 -17,196 -17,226 -19,729 -19,793 -19,455 33.68%
Tax Rate - - - - - - - -
Total Cost 35,829 23,314 20,384 19,605 20,237 20,351 19,917 47.65%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -528.69 -509.04 -539.40 -724.09 -3,883.66 -3,547.13 -4,211.04 -74.76%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -4.91 -4.26 -3.76 -3.92 -4.60 -4.66 -4.67 3.38%
EPS Diluted -4.91 -4.26 -3.76 -3.92 -4.49 -4.66 -4.67 3.38%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.